Otsuka Pakistan Limited (PSX:OTSU)
Pakistan · Delayed Price · Currency is PKR 338.50
-1.46 (-0.43%)
At close: Sep 17, 2026
Otsuka Pakistan Revenue
In the fiscal year ending June 30, 2026, Otsuka Pakistan had annual revenue of 4.11B PKR with 8.77% growth. Otsuka Pakistan had revenue of 1.07B in the quarter ending June 30, 2026, a decrease of -3.66%.
Revenue
4.11B
Revenue Growth
+8.77%
P/S Ratio
1.00
Revenue / Employee
10.08M
Employees
408
Market Cap
4.10B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 4.11B | 331.59M | 8.77% |
| Jun 30, 2025 | 3.78B | 615.65M | 19.46% |
| Jun 30, 2024 | 3.16B | 128.78M | 4.24% |
| Jun 30, 2023 | 3.04B | 183.35M | 6.43% |
| Jun 30, 2022 | 2.85B | 305.46M | 12.00% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Abbott Laboratories (Pakistan) | 77.02B |
| GlaxoSmithKline Pakistan | 67.12B |
| The Searle Company | 35.99B |
| Highnoon Laboratories | 28.50B |
| AGP Limited | 27.70B |
| Ferozsons Laboratories | 22.68B |
| Citi Pharma | 13.84B |
| Macter International | 11.95B |